AI Act Recital 147 EN
LLM context A cited markdown file you can paste into your AI assistant (ChatGPT, Claude, a RAG or project knowledge base) to ground it in this law. Contains: the full text of every article, recital and provision of this law. Everything links back to its source on overview.legal — legal information, not advice.

Recital 147 — access to testing and experimentation facilities

Conformity Assessment for AI Systems Provider Obligations for AI Systems Healthcare
In force — consolidated2026-07-27 · CELEX 02024R1689-20260727 · ELI ↗
Version history 2
  • 2026-07-27in force CELEX 02024R1689-20260727
  • 2024-07-12 CELEX 02024R1689-20240712

It is appropriate that the Commission facilitates, to the extent possible, access to testing and experimentation facilities to bodies, groups or laboratories established or accredited pursuant to any relevant Union harmonisation legislation and which fulfil tasks in the context of conformity assessment of products or devices covered by that Union harmonisation legislation. This is, in particular, the case as regards expert panels, expert laboratories and reference laboratories in the field of medical devices pursuant to Regulations (EU) 2017/745 and (EU) 2017/746.

Related across sources

Literature REGULATION OF APPLIED ARTIFICIAL INTELLIGENCE IN BIOMEDICAL ENGINEERING AS A HIGH-RISK ARTIFICIAL INTELLIGENCE SYSTEM IN THE EU AI ACT Literature The ethics of regulation: Social contract insights on the 2024 European Union Artificial Intelligence Act Literature General-Purpose AI under the EU AI Act: A Conceptual Allocation of Duties across the Value Chain Literature Italy’s Artificial Intelligence Act and Global AI Governance: The EU Model’s Practice and Prospects News Is the AI Act caging ChatGPT and other General Purpose Artificial Intelligence systems? News Meta Must Stop Silencing Reproductive Health Information